Tegaderm™ CHG I.V. Securement Dressing is the only transparent dressing proven to reduce CRBSI and vascular catheter colonization that aligns with evidence-based guidelines and practice standards. The dressing provides four essential elements you need to protect I.V. sites in one integrated, easy-to-use product.
Tegaderm™ CHG I.V. Securement Dressings have been the subject of several clinical studies by leading researchers in infection prevention and infusion therapy. Read more about how Tegaderm™ CHG I.V. Securement Dressings provide better performance, support clinical best practices, and reduce CRBSI and vascular catheter colonization.
Tegaderm™ CHG I.V. Securement Dressing deliver immediate and continuous CHG protection for up to 7 days,* plus all the benefits of our Tegaderm™ I.V. Advanced Securement Dressing. The CHG gel pad is designed to conform around the catheter and hub. The integrated transparent gel pad provides continued visibility to the insertion site.
The integrated design allows for constant site monitoring, aligning with evidence-based guidelines and practice standards. The full line of Tegaderm™ CHG Dressings integrate securement features and CHG impregnated gel pads—features designed to provide consistent I.V. site protection.
Are your patients clearly protected against CRBSI? Tegaderm™ CHG I.V. Securement Dressing is the only transparent dressing proven to reduce CRBSI, featuring a 60% reduction of CRBSIs in a randomized control trial¹ and 100% correct application of the CHG².
The 3M™ PEAK™ Clinical Outcomes Program gives you access to a team of 3M Clinical Specialists and a robust portfolio of tools to help you navigate IV care obstacles and implement change.
As your partner in protecting patients, we want to do everything in our power to help you achieve your goal of zero bloodstream infections. Learn more about free educational resources and evidence-based products to help you stop bloodstream infections before they start.
Thank you for connecting with 3M! We’ll be in touch with you shortly.
An error has occurred while submitting. Please try again later...